Catalyst Wire Dossier Catalyst Wire Dossier

Estradiol/Norethindrone Acetate Tablets

estradiol/norethindrone acetate · Teva Pharmaceuticals USA
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Estradiol/Norethindrone Acetate Tablets, covering 2010-10-07 to 2010-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fasting Conditions [Phase 1]

See pricing